03.05.2023The Bodenmiller lab and collaborators receive 2 mCHF for the CCCZ Lighthouse Project "IMMUNO-CAR ZURICH"

IMMUNO-CAR ZURICH aims to develop innovative platforms within the  Comprehensive Cancer Center Zurich (CCCZ) for the effective, flexible, safe and cost-efficient production of Chimeric Antigen Receptor (CAR) immune cells, which will be manufactured at Wyss Zurich and subsequently used in Phase I clinical trials in patients with an urgent need for effective therapies. This highly translational, patient-centered approach is accompanied by state-of-the-art immune monitoring during therapy and research to improve the efficacy of CAR cells.

Read more about the IMMUNO-CAR ZURICH project on the CCCZ website